摘要

We designed a novel recombinant fusion protein r-NAP5-hirudin 12-residue- RGD with bi-functional inhibitory activities against platelet aggregation and thrombin. Our strategy may supply a potential multi-functional drug for the prevention and management of thrombosis.

全文